Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”

Detalles Bibliográficos
Autores principales: Liu, Hua, Cheng, Jing, Xu, Heng, Wan, Zhenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026228/
https://www.ncbi.nlm.nih.gov/pubmed/35528278
http://dx.doi.org/10.1515/biol-2022-0049
_version_ 1784691073650524160
author Liu, Hua
Cheng, Jing
Xu, Heng
Wan, Zhenzhen
author_facet Liu, Hua
Cheng, Jing
Xu, Heng
Wan, Zhenzhen
author_sort Liu, Hua
collection PubMed
description
format Online
Article
Text
id pubmed-9026228
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-90262282022-05-06 Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis” Liu, Hua Cheng, Jing Xu, Heng Wan, Zhenzhen Open Life Sci Retraction De Gruyter 2022-04-21 /pmc/articles/PMC9026228/ /pubmed/35528278 http://dx.doi.org/10.1515/biol-2022-0049 Text en © 2022 Hua Liu et al., published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Retraction
Liu, Hua
Cheng, Jing
Xu, Heng
Wan, Zhenzhen
Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
title Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
title_full Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
title_fullStr Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
title_full_unstemmed Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
title_short Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
title_sort retraction of “lidocaine has antitumor effect on hepatocellular carcinoma via the circ_dync1h1/mir-520a-3p/usp14 axis”
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026228/
https://www.ncbi.nlm.nih.gov/pubmed/35528278
http://dx.doi.org/10.1515/biol-2022-0049
work_keys_str_mv AT liuhua retractionoflidocainehasantitumoreffectonhepatocellularcarcinomaviathecircdync1h1mir520a3pusp14axis
AT chengjing retractionoflidocainehasantitumoreffectonhepatocellularcarcinomaviathecircdync1h1mir520a3pusp14axis
AT xuheng retractionoflidocainehasantitumoreffectonhepatocellularcarcinomaviathecircdync1h1mir520a3pusp14axis
AT wanzhenzhen retractionoflidocainehasantitumoreffectonhepatocellularcarcinomaviathecircdync1h1mir520a3pusp14axis

Ejemplares similares